Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

By sjmartinez • March 12, 2024

Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918. Cancers (Basel). 2024 Mar 1;16(5):1026. doi: 10.3390/cancers16051026. Erratum for: Cancers (Basel). 2020 Jul 16;12(7): PMID: 38473438.

Tags: Endocrinology, General Internal Medicine, King Drew Med Ctr, Publications

A protocol for noninvasive quantification of dietary fat absorption in mice

Chan AP, Jarrett KE, Lai RW, Clifford BL, Williams KJ, Tarling EJ, de Aguiar Vallim TQ. A protocol for noninvasive quantification of dietary fat absorption[...]

Risk-stratification of pediatric thyroid nodules using ATA and ACR TIRADS adult thyroid nodule scoring systems

Diramerian LG, Douek M, Tse G, Iskander P, Li S, Yeh MW, Livhits MJ, Leung AM, Chiu HK, Wu JX. Risk-stratification of pediatric thyroid nodules[...]

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness

Perini Villanueva G, Solorzano WM, Everett E. Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness. Curr Diab Rep. 2026[...]